Diarrhea
- Human trial5
Trial sponsors
Company1 trialPhase 3150 people
Johns Hopkins Bloomberg School of Public Health
2 trialsPhase 42,200 people
2 trialsPhase 41,543 people
1 trialPhase 472,564 people
1 trialPhase 42,582 people
1 trialPhase 488 people
1 trialPhase 49 people
2 trialsPhase 34,376 people
Funding
1 grant since 2009National Institute of Diabetes and Digestive and Kidney DiseasesUS$576.2k
Latest
10 in 12 monthsContemporary Clinical Trials
Survodutide for the treatment of obesity: Mechanistic rationale, clinical evidence, and remaining uncertainties
Trial in peopleSurvodutide
Science Progress
Association between biological aging and fecal incontinence, chronic diarrhea in U.S. adults: A retrospective cross-sectional analysis based on NHANES data
Cross-sectional study of 5,443 peopleBiomarkers
Diabetes Research and Clinical Practice
Efficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis
Meta-analysisGLP-1 receptor agonists
Digestive Diseases and Sciences
Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis
Cohort study of 6,665 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Petrelintide, a Human Amylin Analog for the Treatment of Obesity: Efficacy and Safety from the Phase 2 Trial, ZUPREME 1
Trial in peopleInterventions
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of cAMP-Biased Ecnoglutide vs. Unbiased Semaglutide in Adults with Obesity: Twenty-Week Results from a Multicenter, Randomized, Open-Label, Phase 2 Study
Trial in peopleInterventions
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Oral Ribupatide (HRS9531) in Adults with Obesity: A Phase 2 Trial
Trial in peopleInterventions
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions
ADA Scientific Sessions 2026 Abstract
MDR-001, an AI-Enabled β-arrestin2-Biased Oral GLP-1RA: Efficacy and Safety in Chinese Adults with Overweight or Obesity
Trial in peopleInterventions
AAIC 2025 Abstract
Neuro‐Metabolic Association in Alzheimer’s Disease and Obesity: Clinical Evaluation of NA‐831 and NA‐931
Trial in peopleInterventions